Johnson Medal Awardees 1 YEAR 2012

First Page		Document Content
Date: 2013-05-22 12:29:43 Organic chemistry Chemistry Ustekinumab Janssen Pharmaceutica Darunavir Paliperidone Golimumab Acuvue Nicorette Centocor Johnson & Johnson Medicine		Johnson Medal Awardees 1 YEAR 2012 Add to Reading List Source URL: www.jnj.com Download Document from Source Website File Size: 165,50 KB Share Document on Facebook

	www.medscape.com/viewarticle/864011_print www.medscape.com DocID: 1pzpz - View Document
	Ixekizumab for moderate to severe chronic plaque psoriasis DocID: 1gyoS - View Document
	438150This information is intended for UK medical media only 00This information is intended for UK medical media only MEDIA RELEASE • MEDIA RELEASE • MEDIA RELEASE CosentyxTM (secukinumab),▼the first IL- DocID: 1fNC6 - View Document
	STELARATM (ustekinumab) STN: BLHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use STELARA™ safely and effectively. See full prescribing information for STE DocID: 1ceTm - View Document
	Janssen Pharmaceutical Companies Product Due Date Status Description of Commitment or Requirement DocID: 1a6Du - View Document